GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other
companies in this sector in PAKISTAN :
Searle Co Ltd
sales of 18.06 billion Pakistan Rupees [US$107.29 million]
of which 79%
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(16.32 billion Pakistan Rupees [US$96.92 million]
of which 100%
was Consumer HealthCare), and
Abbott Laboratories (Pakistan) Ltd
(30.16 billion Pakistan Rupees [US$179.13 million]
of which 70%
During the year ended December of 2019, sales at
GlaxoSmithKline Pakistan Limited were 36.58 billion Pakistan Rupees (US$217.30 million).
increase of 7.6%
versus 2018, when the company's sales were 34.01 billion Pakistan Rupees .
This was the fourth straight year of sales growth at GlaxoSmithKline Pakistan Limited.